Cite
HARVARD Citation
Yap, Y. et al. (2020). Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer science. 111 (9), pp. 3313-3326. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yap, Y. et al. (2020). Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer science. 111 (9), pp. 3313-3326. [Online].